Key result
Novel compound heterozygous LPL mutations cause severe infantile hypertriglyceridemia presenting with lipemia retinalis.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Identifies a novel pathogenic missense variant (c.802C>T; p.His268Tyr) in exon 6 of the LPL gene in compound heterozygosity with p.Arg270Gly as a cause of infantile familial chylomicronemia syndrome.
Lipoprotein lipase (LPL; EC 3.1.1.1.34) is a key enzyme needed for the hydrolysis of triacylglycerol in chylomicrons and very low density lipoproteins.1 LPL deficiency is a rare autosomal recessive disorder with a prevalence of ~1 in 1 000 000 in the United States and higher in other regions of the world.2 LPL deficiency is characterized biochemically by severe hypertriglyceridemia and clinically by features including failure to thrive, eruptive xanthomas, hepatosplenomegaly, recurrent pancreatitis, and lipemia retinalis.2Over 100 mutations in the LPL gene have been found in LPL deficiency. Dietary fat restriction is the mainstay of treatment.3 We report an infant with one novel and one reported mutation within exon 6 of the LPL gene who presented with chylomicronemia, hepatomegaly, and lipemia retinalis.
No takes yet. Share an insight, caveat, or question.
Vidanapathirana et al. (2017) conducted a case report in Lipoprotein lipase (LPL) deficiency (familial chylomicronemia syndrome) (n=1). Low-fat diet, fenofibrate, and omega-3 fish oil was evaluated. Compound heterozygous mutations in LPL exon 6 (novel c.802C>T and reported c.808C>G) caused lipoprotein lipase deficiency in an infant with triglycerides of /dL and lipemia retinalis.
Synapse has enriched 10 related papers. Consider them for comparative context: